Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Uridine Prevents Negative Effects of OXPHOS Xenobiotics on Dopaminergic Neuronal Differentiation.

Iglesias E, Bayona-Bafaluy MP, Pesini A, Garrido-Pérez N, Meade P, Gaudó P, Jiménez-Salvador I, Montoya J, Ruiz-Pesini E.

Cells. 2019 Nov 8;8(11). pii: E1407. doi: 10.3390/cells8111407.

2.

Brain pyrimidine nucleotide synthesis and Alzheimer disease.

Pesini A, Iglesias E, Bayona-Bafaluy MP, Garrido-Pérez N, Meade P, Gaudó P, Jiménez-Salvador I, Andrés-Benito P, Montoya J, Ferrer I, Pesini P, Ruiz-Pesini E.

Aging (Albany NY). 2019 Sep 27;11(19):8433-8462. doi: 10.18632/aging.102328. Epub 2019 Sep 27.

3.

Ketogenic treatment reduces the percentage of a LHON heteroplasmic mutation and increases mtDNA amount of a LHON homoplasmic mutation.

Emperador S, López-Gallardo E, Hernández-Ainsa C, Habbane M, Montoya J, Bayona-Bafaluy MP, Ruiz-Pesini E.

Orphanet J Rare Dis. 2019 Jun 21;14(1):150. doi: 10.1186/s13023-019-1128-z.

4.

Oxidative phosphorylation inducers fight pathological angiogenesis.

Bayona-Bafaluy MP, Esteban O, Ascaso J, Montoya J, Ruiz-Pesini E.

Drug Discov Today. 2019 Sep;24(9):1731-1734. doi: 10.1016/j.drudis.2019.03.014. Epub 2019 Mar 14.

PMID:
30880173
5.

Food derived respiratory complex I inhibitors modify the effect of Leber hereditary optic neuropathy mutations.

López-Gallardo E, Emperador S, Hernández-Ainsa C, Montoya J, Bayona-Bafaluy MP, Ruiz-Pesini E.

Food Chem Toxicol. 2018 Oct;120:89-97. doi: 10.1016/j.fct.2018.07.014. Epub 2018 Jul 6.

PMID:
29991444
6.

Prenatal exposure to oxidative phosphorylation xenobiotics and late-onset Parkinson disease.

Iglesias E, Pesini A, Garrido-Pérez N, Meade P, Bayona-Bafaluy MP, Montoya J, Ruiz-Pesini E.

Ageing Res Rev. 2018 Aug;45:24-32. doi: 10.1016/j.arr.2018.04.006. Epub 2018 Apr 22. Review.

PMID:
29689408
7.

The Decrease in Mitochondrial DNA Mutation Load Parallels Visual Recovery in a Leber Hereditary Optic Neuropathy Patient.

Emperador S, Vidal M, Hernández-Ainsa C, Ruiz-Ruiz C, Woods D, Morales-Becerra A, Arruga J, Artuch R, López-Gallardo E, Bayona-Bafaluy MP, Montoya J, Ruiz-Pesini E.

Front Neurosci. 2018 Feb 9;12:61. doi: 10.3389/fnins.2018.00061. eCollection 2018.

8.

Pharmacologic concentrations of linezolid modify oxidative phosphorylation function and adipocyte secretome.

Llobet L, Bayona-Bafaluy MP, Pacheu-Grau D, Torres-Pérez E, Arbones-Mainar JM, Navarro MÁ, Gómez-Díaz C, Montoya J, López-Gallardo E, Ruiz-Pesini E.

Redox Biol. 2017 Oct;13:244-254. doi: 10.1016/j.redox.2017.05.026. Epub 2017 May 31.

9.

Molecular-genetic characterization and rescue of a TSFM mutation causing childhood-onset ataxia and nonobstructive cardiomyopathy.

Emperador S, Bayona-Bafaluy MP, Fernández-Marmiesse A, Pineda M, Felgueroso B, López-Gallardo E, Artuch R, Roca I, Ruiz-Pesini E, Couce ML, Montoya J.

Eur J Hum Genet. 2016 Jan;25(1):153-156. doi: 10.1038/ejhg.2016.124. Epub 2016 Sep 28.

10.

An MRPS12 mutation modifies aminoglycoside sensitivity caused by 12S rRNA mutations.

Emperador S, Pacheu-Grau D, Bayona-Bafaluy MP, Garrido-Pérez N, Martín-Navarro A, López-Pérez MJ, Montoya J, Ruiz-Pesini E.

Front Genet. 2015 Jan 14;5:469. doi: 10.3389/fgene.2014.00469. eCollection 2014.

11.

OXPHOS, pyrimidine nucleotides, and Alzheimer's disease: a pharmacogenomics approach.

Pesini A, Iglesias E, Garrido N, Bayona-Bafaluy MP, Montoya J, Ruiz-Pesini E.

J Alzheimers Dis. 2014;42(1):87-96. doi: 10.3233/JAD-140384.

PMID:
25024340
12.

The thankless task of playing genetics with mammalian mitochondrial DNA: a 30-year review.

Bayona-Bafaluy MP, Fernández-Silva P, Enríquez JA.

Mitochondrion. 2002 Nov;2(1-2):3-25.

PMID:
16120305

Supplemental Content

Loading ...
Support Center